Skip to main content
Premium Trial:

Request an Annual Quote

Spanish Dx Firm Imegen Acquired in €10M Private Equity Buyout

NEW YORK (GenomeWeb) – Spanish diagnostics company Imegen has been acquired by private equity investors for €10 million ($10.8 million), according to a European news report which the company has confirmed.

Q-Growth Fund and Biolty bought out 41 of the 42 shareholders in the Valencia, Spain-based firm. The investors are also Spanish firms.

Founded in 2009, Imegen specializes in clinical genetics and genomics, offering tests for more than 1,500 human genetic diseases, including cancer and rare diseases; prenatal diagnostics; reproductive screening; and custom assay development. The firm also offers genomic testing for ag-bio applications through Imegenagro.

Imegen CEO Ángela Pérez said in a statement that the proceeds will help professionalize the firm and provide funding to consolidate its business overseas. She will remain a shareholder and will continue to lead the company.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.